186 related articles for article (PubMed ID: 31375100)
1. Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction.
Thisted T; Biesova Z; Walmacq C; Stone E; Rodnick-Smith M; Ahmed SS; Horrigan SK; Van Engelen B; Reed C; Kalnik MW
BMC Biotechnol; 2019 Aug; 19(1):56. PubMed ID: 31375100
[TBL] [Abstract][Full Text] [Related]
2. Crystallography Coupled with Kinetic Analysis Provides Mechanistic Underpinnings of a Nicotine-Degrading Enzyme.
Tararina MA; Xue S; Smith LC; Muellers SN; Miranda PO; Janda KD; Allen KN
Biochemistry; 2018 Jul; 57(26):3741-3751. PubMed ID: 29812904
[TBL] [Abstract][Full Text] [Related]
3. The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats.
Pentel PR; Raleigh MD; LeSage MG; Thisted T; Horrigan S; Biesova Z; Kalnik MW
BMC Biotechnol; 2018 Jul; 18(1):46. PubMed ID: 30041697
[TBL] [Abstract][Full Text] [Related]
4. Structural Analysis Provides Mechanistic Insight into Nicotine Oxidoreductase from Pseudomonas putida.
Tararina MA; Janda KD; Allen KN
Biochemistry; 2016 Dec; 55(48):6595-6598. PubMed ID: 27933790
[TBL] [Abstract][Full Text] [Related]
5. Fast Kinetics Reveals Rate-Limiting Oxidation and the Role of the Aromatic Cage in the Mechanism of the Nicotine-Degrading Enzyme NicA2.
Tararina MA; Dam KK; Dhingra M; Janda KD; Palfey BA; Allen KN
Biochemistry; 2021 Feb; 60(4):259-273. PubMed ID: 33464876
[TBL] [Abstract][Full Text] [Related]
6. Molecular Deceleration Regulates Toxicant Release to Prevent Cell Damage in Pseudomonas putida S16 (DSM 28022).
Tang H; Zhang K; Hu H; Wu G; Wang W; Zhu X; Liu G; Xu P
mBio; 2020 Sep; 11(5):. PubMed ID: 32873764
[TBL] [Abstract][Full Text] [Related]
7. A New Strategy for Smoking Cessation: Characterization of a Bacterial Enzyme for the Degradation of Nicotine.
Xue S; Schlosburg JE; Janda KD
J Am Chem Soc; 2015 Aug; 137(32):10136-9. PubMed ID: 26237398
[TBL] [Abstract][Full Text] [Related]
8. A cytochrome c is the natural electron acceptor for nicotine oxidoreductase.
Dulchavsky M; Clark CT; Bardwell JCA; Stull F
Nat Chem Biol; 2021 Mar; 17(3):344-350. PubMed ID: 33432238
[TBL] [Abstract][Full Text] [Related]
9. The enzyme pseudooxynicotine amine oxidase from Pseudomonas putida S16 is not an oxidase, but a dehydrogenase.
Choudhary V; Wu K; Zhang Z; Dulchavsky M; Barkman T; Bardwell JCA; Stull F
J Biol Chem; 2022 Aug; 298(8):102251. PubMed ID: 35835223
[TBL] [Abstract][Full Text] [Related]
10. An enzymatic advance in nicotine cessation therapy.
Xue S; Kallupi M; Zhou B; Smith LC; Miranda PO; George O; Janda KD
Chem Commun (Camb); 2018 Feb; 54(14):1686-1689. PubMed ID: 29308799
[TBL] [Abstract][Full Text] [Related]
11. Directed evolution unlocks oxygen reactivity for a nicotine-degrading flavoenzyme.
Dulchavsky M; Mitra R; Wu K; Li J; Boer K; Liu X; Zhang Z; Vasquez C; Clark CT; Funckes K; Shankar K; Bonnet-Zahedi S; Siddiq M; Sepulveda Y; Suhandynata RT; Momper JD; Calabrese AN; George O; Stull F; Bardwell JCA
Nat Chem Biol; 2023 Nov; 19(11):1406-1414. PubMed ID: 37770699
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Pseudooxynicotine Amine Oxidase of Pseudomonas putida S16 that Is Crucial for Nicotine Degradation.
Hu H; Wang W; Tang H; Xu P
Sci Rep; 2015 Dec; 5():17770. PubMed ID: 26634650
[TBL] [Abstract][Full Text] [Related]
13. An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse.
Kallupi M; Xue S; Zhou B; Janda KD; George O
Sci Adv; 2018 Oct; 4(10):eaat4751. PubMed ID: 30345354
[TBL] [Abstract][Full Text] [Related]
14. Improving the kinetic parameters of nicotine oxidizing enzymes by homologous structure comparison and rational design.
Deay DO; Seibold S; Battaile KP; Lovell S; Richter ML; Petillo PA
Arch Biochem Biophys; 2022 Mar; 718():109122. PubMed ID: 35063417
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase and tobacco dependence.
Lewis A; Miller JH; Lea RA
Neurotoxicology; 2007 Jan; 28(1):182-95. PubMed ID: 16859748
[TBL] [Abstract][Full Text] [Related]
16. Functional identification of two novel genes from Pseudomonas sp. strain HZN6 involved in the catabolism of nicotine.
Qiu J; Ma Y; Wen Y; Chen L; Wu L; Liu W
Appl Environ Microbiol; 2012 Apr; 78(7):2154-60. PubMed ID: 22267672
[TBL] [Abstract][Full Text] [Related]
17. A novel NADH-dependent and FAD-containing hydroxylase is crucial for nicotine degradation by Pseudomonas putida.
Tang H; Yao Y; Zhang D; Meng X; Wang L; Yu H; Ma L; Xu P
J Biol Chem; 2011 Nov; 286(45):39179-87. PubMed ID: 21949128
[TBL] [Abstract][Full Text] [Related]
18. Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies.
Raleigh MD; Beltraminelli N; Fallot S; LeSage MG; Saykao A; Pentel PR; Fuller S; Thisted T; Biesova Z; Horrigan S; Sampey D; Zhou B; Kalnik MW
PLoS One; 2021; 16(7):e0254247. PubMed ID: 34329335
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional identification of two homologous nicotine dehydrogenases, NicA2 and Nox, from Pseudomonas sp. JY-Q.
Li J; Shen M; Chen Z; Pan F; Yang Y; Shu M; Chen G; Jiao Y; Zhang F; Linhardt RJ; Zhong W
Protein Expr Purif; 2021 Feb; 178():105767. PubMed ID: 32987121
[TBL] [Abstract][Full Text] [Related]
20. Function Enhancement of a Metabolic Module via Endogenous Promoter Replacement for Pseudomonas sp. JY-Q to Degrade Nicotine in Tobacco Waste Treatment.
Li J; Yi F; Chen G; Pan F; Yang Y; Shu M; Chen Z; Zhang Z; Mei X; Zhong W
Appl Biochem Biotechnol; 2021 Sep; 193(9):2793-2805. PubMed ID: 34061306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
